1. Home
  2. ARCT vs WLDN Comparison

ARCT vs WLDN Comparison

Compare ARCT & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • WLDN
  • Stock Information
  • Founded
  • ARCT 2013
  • WLDN 1964
  • Country
  • ARCT United States
  • WLDN United States
  • Employees
  • ARCT N/A
  • WLDN N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • WLDN Military/Government/Technical
  • Sector
  • ARCT Health Care
  • WLDN Consumer Discretionary
  • Exchange
  • ARCT Nasdaq
  • WLDN Nasdaq
  • Market Cap
  • ARCT 487.0M
  • WLDN 581.0M
  • IPO Year
  • ARCT N/A
  • WLDN 2006
  • Fundamental
  • Price
  • ARCT $16.74
  • WLDN $38.23
  • Analyst Decision
  • ARCT Strong Buy
  • WLDN Strong Buy
  • Analyst Count
  • ARCT 7
  • WLDN 3
  • Target Price
  • ARCT $65.00
  • WLDN $44.33
  • AVG Volume (30 Days)
  • ARCT 388.1K
  • WLDN 114.9K
  • Earning Date
  • ARCT 03-06-2025
  • WLDN 03-06-2025
  • Dividend Yield
  • ARCT N/A
  • WLDN N/A
  • EPS Growth
  • ARCT N/A
  • WLDN 802.09
  • EPS
  • ARCT N/A
  • WLDN 1.63
  • Revenue
  • ARCT $160,399,000.00
  • WLDN $577,414,000.00
  • Revenue This Year
  • ARCT $7.33
  • WLDN N/A
  • Revenue Next Year
  • ARCT $4.71
  • WLDN $7.28
  • P/E Ratio
  • ARCT N/A
  • WLDN $23.78
  • Revenue Growth
  • ARCT N/A
  • WLDN 23.47
  • 52 Week Low
  • ARCT $14.30
  • WLDN $18.37
  • 52 Week High
  • ARCT $45.00
  • WLDN $50.00
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 46.33
  • WLDN 46.80
  • Support Level
  • ARCT $16.07
  • WLDN $34.73
  • Resistance Level
  • ARCT $17.51
  • WLDN $39.09
  • Average True Range (ATR)
  • ARCT 1.44
  • WLDN 1.12
  • MACD
  • ARCT -0.11
  • WLDN 0.33
  • Stochastic Oscillator
  • ARCT 15.43
  • WLDN 79.55

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

Share on Social Networks: